These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26259996)

  • 1. Predictive Bayesian inference and dynamic treatment regimes.
    Saarela O; Arjas E; Stephens DA; Moodie EE
    Biom J; 2015 Nov; 57(6):941-58. PubMed ID: 26259996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian inference for optimal dynamic treatment regimes in practice.
    Rodriguez Duque D; Moodie EEM; Stephens DA
    Int J Biostat; 2023 Nov; 19(2):309-331. PubMed ID: 37192544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal dynamic regimes: presenting a case for predictive inference.
    Arjas E; Saarela O
    Int J Biostat; 2010 Mar; 6(2):Article 10. PubMed ID: 20648215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On Bayesian estimation of marginal structural models.
    Saarela O; Stephens DA; Moodie EE; Klein MB
    Biometrics; 2015 Jun; 71(2):279-88. PubMed ID: 25677103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semiparametric Bayesian inference for optimal dynamic treatment regimes via dynamic marginal structural models.
    Rodriguez Duque D; Stephens DA; Moodie EEM; Klein MB
    Biostatistics; 2023 Jul; 24(3):708-727. PubMed ID: 35385100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of dynamic treatment regimes via inverse probability weighting.
    Hernán MA; Lanoy E; Costagliola D; Robins JM
    Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):237-42. PubMed ID: 16611197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demystifying optimal dynamic treatment regimes.
    Moodie EE; Richardson TS; Stephens DA
    Biometrics; 2007 Jun; 63(2):447-55. PubMed ID: 17688497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of parameter uncertainty for an activated sludge model using Bayesian inference: a comparison with the frequentist method.
    Zonta ZJ; Flotats X; Magrí A
    Environ Technol; 2014 Aug; 35(13-16):1618-29. PubMed ID: 24956752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A semiparametric Bayesian approach to the random effects model.
    Kleinman KP; Ibrahim JG
    Biometrics; 1998 Sep; 54(3):921-38. PubMed ID: 9750242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneous growth bent-cable models for time-to-event and longitudinal data: application to AIDS studies.
    Dagne GA
    J Biopharm Stat; 2018; 28(6):1216-1230. PubMed ID: 29953318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian inference on joint models of HIV dynamics for time-to-event and longitudinal data with skewness and covariate measurement errors.
    Huang Y; Dagne G; Wu L
    Stat Med; 2011 Oct; 30(24):2930-46. PubMed ID: 21805486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating the causal effect of zidovudine on CD4 count with a marginal structural model for repeated measures.
    Hernán MA; Brumback BA; Robins JM
    Stat Med; 2002 Jun; 21(12):1689-709. PubMed ID: 12111906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatiotemporal Bayesian inference dipole analysis for MEG neuroimaging data.
    Jun SC; George JS; Paré-Blagoev J; Plis SM; Ranken DM; Schmidt DM; Wood CC
    Neuroimage; 2005 Oct; 28(1):84-98. PubMed ID: 16023866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-robust estimators: slightly more Bayesian than meets the eye?
    Gustafson P
    Int J Biostat; 2012 Jan; 8(2):. PubMed ID: 22499730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On optimal treatment regimes selection for mean survival time.
    Geng Y; Zhang HH; Lu W
    Stat Med; 2015 Mar; 34(7):1169-84. PubMed ID: 25515005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayesian inference for stochastic multitype epidemics in structured populations using sample data.
    O'Neill PD
    Biostatistics; 2009 Oct; 10(4):779-91. PubMed ID: 19648227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A refreshing account of principal stratification.
    Mealli F; Mattei A
    Int J Biostat; 2012; 8(1):. PubMed ID: 22611592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Bayesian framework for intent-to-treat analysis with missing data.
    Kleinman KP; Ibrahim JG; Laird NM
    Biometrics; 1998 Mar; 54(1):265-78. PubMed ID: 9544521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large-sample Bayesian posterior distributions for probabilistic sensitivity analysis.
    Hazen GB; Huang M
    Med Decis Making; 2006; 26(5):512-34. PubMed ID: 16997928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A practical introduction to Bayesian estimation of causal effects: Parametric and nonparametric approaches.
    Oganisian A; Roy JA
    Stat Med; 2021 Jan; 40(2):518-551. PubMed ID: 33015870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.